HBVM阳性肺结核病人用利福喷丁或利福平治疗肝功能损害观察

中国防痨杂志 ›› 1999, Vol. 21 ›› Issue (4): 206-207.

HBVM阳性肺结核病人用利福喷丁或利福平治疗肝功能损害观察

李东方；

安徽省肺科医院 230022;

收稿日期:1999-04-01 修回日期:1999-07-28 出版日期:1999-04-10 发布日期:1999-04-10

Observation of the effect on liver function in pulmonary tuberculosis with positive HBVM treated with rifapentine or rifampicin

Li Dongfang.

Anhui Lung Hospital,Hefei 230022

Received:1999-04-01 Revised:1999-07-28 Online:1999-04-10 Published:1999-04-10

摘要/Abstract

摘要： 目的观察利福喷丁?利福平对HBVM 阳性肺结核病人肝功能的影响?方法对HBVM 阳性和阴性肺结核病人分别用利福喷丁和利福平治疗,观察治疗前后肝功能损害情况?结果利福平组较利福喷丁组出现肝损害多( P< 0-01) ;HBVM 阳性较阴性病人易出现肝损害( P< 0-01) ;利福平组HBVM 阳性较阴性病人出现肝损害多( P< 0-01) ;利福喷丁组HBVM 阳性和阴性肝损害发生率无显著差异( P> 0-05) ?结论抗结核治疗时HBVM 阳性比阴性病人更易发生肝损害,与其用药前即存在肝病理损害有关,治疗肺结核用利福喷丁比利福平疗效好且安全?

关键词: 结核,肺, 乙肝病毒标志物, 利福类药物, 肝损害

Abstract: Objective To evaluate the effect on liver function in pulmonary tuberculosis with positive HBVM treated with rifapentine or rifampicin.Method In HBVM positive group and negative group treated with rifapentine or rifampicin,liver function injury were observed before and after treatment.Results The incidence of liver injury in treated rifampicin group is higher than that in treated rifapentine group( P<0.01).The incidence of liver injury in HBVM positive group is higher than that in HBVM negative group( P<0 01).In treated rifampicin group,the incidence of liver injury in HBVM positive group is higher than that in HBVM negative group( P<0.01).In treated rifapentine group showed liver injury no significant differences( P >0 05).Conclusion The incidence of liver injury in HBVM positive group is higher than that in HBVM negative group because liver injury exists in the former before treatment.In the treatment of pulmonary tuberculosis,using rifapentine is better and safer.

Key words: Tuberculosis, pulmouary, HBVM, Rifamycin agents

李东方, . HBVM阳性肺结核病人用利福喷丁或利福平治疗肝功能损害观察[J]. 中国防痨杂志, 1999, 21(4): 206-207.

Li Dongfang.. Observation of the effect on liver function in pulmonary tuberculosis with positive HBVM treated with rifapentine or rifampicin[J]. Chinese Journal of Antituberculosis, 1999, 21(4): 206-207.

[1]	李爽孙力丛登立. 甘利欣治疗抗结核药物所致肝损害的临床疗效观察[J]. 中国防痨杂志, 2011, 33(6): 385-386.
[2]	何丙生代秀萍李双初陈晖郭玉霞胡秀琼玉海花叶龙玲. HBsAg、HBeAg、HBcAb阳性初治肺结核患者的抗结核化疗经验[J]. 中国防痨杂志, 2011, 33(5): 315-317.
[3]	李福建, 张贵贤, 刘芳. 抗结核药所致重症肝损害4例[J]. 中国防痨杂志, 2010, 32(10): 81-82.
[4]	林志来,施振慧,翁恒,林友飞,陈力舟,林剑东,朱玉芳,. “力克菲蒺、利福喷汀、阿米卡星、左氧氟沙星”方案对肝损害肺结核疗效及安全性观察[J]. 中国防痨杂志, 2006, 28(4): 238-240.
[5]	袁保东,王卫华,段琼红,张炎林,陆兰英. 耐多药肺结核患者生命质量的评价[J]. 中国防痨杂志, 2006, 28(3): 139-142.
[6]	谭守勇,林兆原,关玉华,李嫣红,潘爱华,黎燕琼,粱敏青,. 蛋白质营养不良对抗结核药物肝损害的影响[J]. 中国防痨杂志, 2006, 28(2): 83-86.
[7]	董安国,许金云,崔冬梅,. 西利宾胺预防抗结核药物肝损害的临床观察[J]. 中国防痨杂志, 2005, 27(2): 104-106.
[8]	陈佳怀,许卓磐,. 汕头市区1998—2002年初治涂阳肺结核病人抗结核治疗引起肝损害情况分析[J]. 中国防痨杂志, 2004, 26(4): 242-244.
[9]	何连福,刘亮平,吴世林,. 螺旋藻预防抗结核药物引起肝损害的临床观察[J]. 中国防痨杂志, 2000, 22(4): 225-226.